PROACT-4 Trial design: Patients enroute to the hospital with acute chest pain were randomized to point of care troponin testing (n = 305) vs. usual care.

Slides:



Advertisements
Similar presentations
Introduction: In the setting of a suspected acute coronary syndrome (ACS), aspirin (ASA) is the primary treatment used for platelet inhibition. However,
Advertisements

Roles and Responsibilities
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
LTC and the Hospital Jeffrey P Schaefer, MD slide update available at dr.schaeferville.com.
NHS 24 and the Scottish Ambulance Service Dr George Crooks Medical Director NHS24 and SAS.
Immunomodulation of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Renal Replacement Therapy Sasipha Tachaboon 1, Khajohn Tiranatanakul.
55a. Percentage of construction workers who had no consistent place to receive care when sick, by insurance status and Hispanic ethnicity, 2010 (All employment)
 Sleep: Treatment and Cause for Low Back Pain Kevin Carneiro, D.O. University of North Carolina, Chapel Hill.
Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.
Making a difference-Infection Prevention Dr Emma Watson Consultant Microbiologist Stockport NHS Foundation Trust.
Components of an EMS System Information Adapted from:
FIGURES Chapter 5, Instructor’s Manual. © 2006 by John R. Griffith and Kenneth R. White FIGURE 5.1 Decision Tree for Evaluating Surgical Treatment for.
Please do NOT resuscitate a pediatric patient in SHOCK with an infusion pump Could this be Sepsis? Ask… “Could this be Sepsis?” Sepsis is a medical emergency.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: One-Hour Rule-out and Rule-in of Acute Myocardial.
(p for noninferiority = 0.01)
Insights on emergency care
The American College of Cardiology Presented by Dr. Adnan Kastrati
The American College of Cardiology Presented by Dr. Adnan Kastrati
BAPAM Flowchart : What to do if you suspect a child or young adult is being abused or neglected? Do you suspect a child or young adult is being abused.
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
APEX Trial design: Patients hospitalized with an acute medical illness were randomized to oral betrixaban for days (n = 3,759) versus subcutaneous.
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Severity of incidents by care setting, April 2006 to March 2007
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Figure 1 : Pediatric Emergency Department Quality Assessment Scale
Staffing incidents as a proportion of all incident types by specialty
Urology on call pathway
(CMR vs. guidelines, p < 0.001)
Copyright © 2013 American Medical Association. All rights reserved.
56a. Percentage of construction workers who had no consistent place to receive care when sick, by insurance status and Hispanic ethnicity, 2015.
DANISH Trial design: Patients with nonischemic cardiomyopathy were randomized to ICD implantation (n = 556) versus usual care (n = 560). Results (p = 0.28)
EUCLID Trial design: Patients with peripheral arterial disease (PAD) were randomized to ticagrelor 90 mg twice daily (n = 6,930) vs. clopidogrel 75 mg.
LEVO-CTS Trial design: Patients undergoing cardiac surgery with the use of cardiopulmonary bypass were randomized to infusion of levosimendan 0.2 µg/kg/min.
EVITA Trial design: Smokers admitted with an acute coronary syndrome were randomized to varenicline 1 mg twice daily (n = 151) vs. placebo (n = 151). Study.
INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.
OptiLink HF Trial design: Patients with heart failure who underwent implantation of an ICD were randomized to telemonitoring (n = 505) vs. usual care (n.
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
PARADIGM-HF Trial design: Participants with NYHA class II-IV and LVEF ≤40% were randomized to LCZ mg twice daily (n = 4,187) vs. enalapril 10 mg.
Choose the right care this Easter
MOBILE Trial design: Patients with critical limb ischemia were randomized to intramuscular injection of bone marrow-derived stem cells (n = 119) vs. placebo.
ODYSSEY FH I and II Trial design: Participants with heterozygous familial hypercholesterolemia on statin therapy were randomized to alirocumab 75 mg SQ.
VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =
Vanderbilt Emergency Department Renovation Project
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
EXCITE ISR Trial design: Participants with femoropopliteal in-stent restenosis were randomized to excimer laser atherectomy + adjunctive angioplasty (n.
FAMOUS-NSTEMI Trial design: Participants with NSTEMI were randomized to an FFR-guided strategy (n = 176) vs. a coronary angiography-guided strategy (n.
Invasive versus conservative treatment in unstable coronary syndromes
Randomized Comparison in the Setting of Acute MI
ALBATROSS Trial design: Patients with MI without heart failure were randomized to an IV bolus of potassium canrenoate 200 mg as early as possible, then.
After Eighty Study Trial design: Elderly patients with non–ST-elevation acute coronary syndrome (NSTE-ACS) were randomized to invasive therapy (n = 229)
EXPLORE Trial design: Patients with STEMI treated with primary PCI and with evidence of noninfarct artery chronic total occlusion (CTO) were randomized.
American College of Cardiology Presented by Dr. Michel R. Le May
(p-value between groups = 0.59)
ATHENA-HF Trial design: Patients with acute heart failure were randomized to spironolactone 100 mg daily (n = 182) vs. placebo/low-dose spironolactone.
TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.
Anaerobic threshold responder analysis
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.
Remote ischemic preconditioning
TRUE-AHF Trial design: Patients with acute decompensated heart failure were randomized in a 1:1 fashion to either early ularitide infusion (within 12 hours)
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
SOLID-TIMI 52 Trial design: Participants within 30 days of an acute coronary syndrome (ACS) were randomized to darapladib 160 mg daily (n = 6,504) versus.
Acute coronary syndromes: diagnosis
OPTIDUAL Trial design: Patients who received a drug-eluting stent and were event-free at 12 months were randomized to an additional 36 months of DAPT with.
Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.
MATRIX: Radial vs. Femoral
MOOD-HF Trial design: Patients with chronic systolic heart failure and comorbid depression were randomized to escitalopram (n = 185) vs. placebo (n = 187).
(p for non-inferiority < 0.001)
The Need for Serial Troponin Testing absolute cTn elevations are seen in multiple chronic cardiac and noncardiac conditions rise or fall !! in serial.
TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
Presentation transcript:

PROACT-4 Trial design: Patients enroute to the hospital with acute chest pain were randomized to point of care troponin testing (n = 305) vs. usual care (n = 296). Results (p = 0.074) Time from first medical contact to final disposition in the emergency department: 8.9 hours in the point of care group vs. 9.1 hours in the usual care group (p = 0.074) All-cause death: 1.3% for point of care vs. 1.4% for usual care (p = 0.97) 8.9 9.1 Hours Conclusions Among patients presenting to the hospital with acute chest pain, point of care troponin testing in the ambulance nonsignificantly reduced the time from first medical contact to final disposition in the emergency department Point of care testing Usual care group Presented by Dr. Justin Ezekowitz at AHA 2015